Renata PLC manufactures, markets, and distributes human pharmaceuticals, animal health medicines, nutritionals, and vaccines in Bangladesh. Its pharmaceutical products include antimicrobials, anti-hypertensive, anti-angina, anti-diabetic, eye-ear and topical preparation, antigout, NSAID, anti-spasmodic, steroid, anti-osteoporotic, anti-allergic, cardiovascular, CNS, hormone, anti-cancer, oxytocic, anti-fibrinolytic, anti-asthma, expectorant, oral rehydration saline, narcotic analgesic, antipyretic/analgesic, antiemetic, anesthetic, antiviral, and other products. The company offers lipid lowering, antiulcer, anti-parasitic and anti-protozoal, anti-fungal, anti-tuberculosis, and gastroprokinetic agents; and vitamins and minerals. Its animal health products comprise antibiotic, cephalosporin, sulphonamides, anthelmintic, antiprotozoal, anti-histaminic, NSAID, glucocorticoid, appetizer and rumenotoric, and metabolic products, as well as vitamin-mineral and anti-fibrinolytic; and anthelmintic, anti-coccidial, anti-gout, electrolyte, nutritional premix, nutrition products, imported, and hormone products, as well as poultry and aqua products, and live and killed vaccines. In addition, the company provides oncology-based products; agro-based products; poultry products; and consumer products. The company was formerly known as Pfizer Laboratories (Bangladesh) Limited and changed its name to Renata Limited in 1993. Renata PLC was incorporated in 1972 and is headquartered in Dhaka, Bangladesh.
Metrics to compare | RNTL | Peers Peers - average of corresponding metrics from companies closely matching RNTL: ADVENT, CENTRALPHL, TECHNODRUG, SQURPHARMA, ORIONPHARM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRNTLPeersSector |
---|---|---|---|---|
P/E Ratio | 20.0x | 16.7x | −0.5x | |
PEG Ratio | 0.88 | −0.63 | 0.00 | |
Price/Book | 1.6x | 1.4x | 2.6x | |
Price / LTM Sales | 1.4x | 2.5x | 3.2x | |
Upside (Analyst Target) | 43.4% | 51.3% | 44.6% | |
Fair Value Upside | Unlock | 6.2% | 6.5% | Unlock |